We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+1.71%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
AUM
$863M
AUM Growth
-$3.38M
Cap. Flow
-$9.53M
Cap. Flow %
-1.1%
Top 10 Hldgs %
32.01%
Holding
55
New
1
Increased
18
Reduced
30
Closed
2

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$27.1M
2
KO icon
Coca-Cola
KO
+$25M
3
CB icon
Chubb
CB
+$5.85M
4
CVX icon
Chevron
CVX
+$4.95M
5
EOG icon
EOG Resources
EOG
+$4.77M

Sector Composition

Rank Sector Weight
1 Healthcare 26.32%
2 Communication Services 12.52%
3 Consumer Staples 9.69%
4 Technology 9.58%
5 Energy 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$290B
$23.8M 2.76%
244,900
-4,750
-2% -$476K
TMO icon
27
Thermo Fisher Scientific
TMO
$223B
$19.9M 2.31%
125,215
-2,570
-2% -$396K
EOG icon
28
EOG Resources
EOG
$75.1B
$19.7M 2.29%
204,100
-54,350
-21% -$4.77M
XOM icon
29
ExxonMobil
XOM
$657B
$18.6M 2.16%
213,485
-31,755
-13% -$2.82M
JNJ icon
30
Johnson & Johnson
JNJ
$629B
$18.4M 2.13%
155,910
-2,100
-1% -$255K
CB icon
31
Chubb
CB
$132B
$18.4M 2.13%
146,150
-46,100
-24% -$5.85M
AMGN icon
32
Amgen
AMGN
$225B
$18.3M 2.12%
109,825
-1,100
-1% -$186K
CVX icon
33
Chevron
CVX
$386B
$17.5M 2.03%
170,350
-48,490
-22% -$4.95M
ABT icon
34
Abbott
ABT
$192B
$16.8M 1.95%
398,215
+4,550
+1% +$195K
CELG
35
DELISTED
Celgene Corp
CELG
$16.3M 1.89%
155,784
+2,600
+2% +$281K
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$2.51M 0.29%
46,600
-900
-2% -$57.8K
KO icon
37
Coca-Cola
KO
$373B
$2.21M 0.26%
52,100
-569,620
-92% -$25M
ADP icon
38
Automatic Data Processing
ADP
$107B
$1.14M 0.13%
12,900
-2,600
-17% -$236K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.08M 0.13%
7,500
FE icon
40
FirstEnergy
FE
$27.2B
$1.07M 0.12%
32,500
LLY icon
41
Eli Lilly
LLY
$1.09T
$1.01M 0.12%
12,600
-4,100
-25% -$328K
CL icon
42
Colgate-Palmolive
CL
$73.6B
$942K 0.11%
12,700
+500
+4% +$37K
IFF icon
43
International Flavors & Fragrances
IFF
$21.4B
$929K 0.11%
6,500
-1,000
-13% -$135K
AAPL icon
44
Apple
AAPL
$4.41T
$927K 0.11%
32,800
+4,800
+17% +$127K
ZBH icon
45
Zimmer Biomet
ZBH
$18.7B
$871K 0.1%
6,901
-1,030
-13% -$127K
COST icon
46
Costco
COST
$421B
$854K 0.1%
5,600
+100
+2% +$16.2K
A icon
47
Agilent Technologies
A
$41.9B
$843K 0.1%
17,900
-2,300
-11% -$107K
GILD icon
48
Gilead Sciences
GILD
$168B
$736K 0.09%
9,300
+300
+3% +$24.4K
SO icon
49
Southern Company
SO
$106B
$621K 0.07%
12,100
-4,000
-25% -$211K
PEP icon
50
PepsiCo
PEP
$189B
$593K 0.07%
5,450

Similar funds

Stralem & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Stralem & Co held 55 positions worth $863M, down 0.39% from $866M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Stralem & Co's Q3 2016 filing shows 1 new, 18 increased, 30 reduced and 2 closed positions. Its largest new stake was Meta Platforms (Facebook): 215,450 shares worth $27.6M. The largest sale was GE Aerospace, an estimated $27.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Communication Services and Consumer Staples.

  • Stralem & Co's largest Q3 2016 buy was Meta Platforms (Facebook): 215,450 shares worth $27.6M.
  • Stralem & Co added most to Kraft Heinz in Q3 2016, an estimated $25.8M increase.
  • Stralem & Co's biggest Q3 2016 reduction was Coca-Cola, cutting an estimated $25M.
  • Stralem & Co fully exited GE Aerospace in Q3 2016, selling an estimated $27.1M.
  • Stralem & Co's ten largest holdings make up 32% of its $863M portfolio in Q3 2016.
  • Stralem & Co opened 1 new position and closed 2 in Q3 2016.
  • Stralem & Co's portfolio value fell 0.39% quarter-over-quarter to $863M.

Based on Stralem & Co's 13F filing for Q3 2016, filed 19 Oct 2016.